K Lyerly - JoVE Visualize

Showing results (21-30 of 94) with videos related to

Pageof 10

Sort By:

Surgical Oncology|February 1, 1992

Effects of cyclosporine on human B-cell lymphoma development in vivoT J Boyle, R E Coles, A M Kizilbash, et al.

Science (New York, N.Y.)|July 24, 1992

Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1S S Hwang, T J Boyle, H K Lyerly, et al.

Science (New York, N.Y.)|July 5, 1991

Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1S S Hwang, T J Boyle, H K Lyerly, et al.

Cancer Research|July 29, 1998

Optimization of the sequence of antigen loading and CD40-ligand-induced maturation of dendritic cellsM A Morse, H K Lyerly, E Gilboa, et al.

Cancer Research|March 8, 2000

Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cellsD Boczkowski, S K Nair, J H Nam, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 15, 1992

Derivation of a biologically contained replication system for human immunodeficiency virus type 1H Chen, T J Boyle, M H Malim, et al.

Thrombosis and Haemostasis|December 29, 2000

Blocking the initiation of coagulation by RNA aptamers to factor VIIaC P Rusconi, A Yeh, H K Lyerly, et al.

Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|August 1, 1996

Paravertebral block for breast cancer surgeryR Greengrass, F O'Brien, K Lyerly, et al.

Annals of Surgery|July 1, 1997

Generation of dendritic cells in vitro from peripheral blood mononuclear cells with granulocyte-macrophage-colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha for use in cancer immunotherapyM A Morse, L J Zhou, T F Tedder, et al.

Molecular Cancer Therapeutics|April 22, 2010

X-linked inhibitor of apoptosis protein inhibits apoptosis in inflammatory breast cancer cells with acquired resistance to an ErbB1/2 tyrosine kinase inhibitorKatherine M Aird, Rami B Ghanayem, Sharon Peplinski, et al.

Pageof 10

Showing results (21-30 of 94) with videos related to

Sort By:

Pageof 10

Surgical Oncology|February 1, 1992

Effects of cyclosporine on human B-cell lymphoma development in vivoT J Boyle, R E Coles, A M Kizilbash, et al.

Science (New York, N.Y.)|July 24, 1992

Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1S S Hwang, T J Boyle, H K Lyerly, et al.

Science (New York, N.Y.)|July 5, 1991

Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1S S Hwang, T J Boyle, H K Lyerly, et al.

Cancer Research|July 29, 1998

Optimization of the sequence of antigen loading and CD40-ligand-induced maturation of dendritic cellsM A Morse, H K Lyerly, E Gilboa, et al.

Cancer Research|March 8, 2000

Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cellsD Boczkowski, S K Nair, J H Nam, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 15, 1992

Derivation of a biologically contained replication system for human immunodeficiency virus type 1H Chen, T J Boyle, M H Malim, et al.

Thrombosis and Haemostasis|December 29, 2000

Blocking the initiation of coagulation by RNA aptamers to factor VIIaC P Rusconi, A Yeh, H K Lyerly, et al.

Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|August 1, 1996

Paravertebral block for breast cancer surgeryR Greengrass, F O'Brien, K Lyerly, et al.

Annals of Surgery|July 1, 1997

Generation of dendritic cells in vitro from peripheral blood mononuclear cells with granulocyte-macrophage-colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha for use in cancer immunotherapyM A Morse, L J Zhou, T F Tedder, et al.

Molecular Cancer Therapeutics|April 22, 2010

X-linked inhibitor of apoptosis protein inhibits apoptosis in inflammatory breast cancer cells with acquired resistance to an ErbB1/2 tyrosine kinase inhibitorKatherine M Aird, Rami B Ghanayem, Sharon Peplinski, et al.

Pageof 10